PolyPid Announces R&D Collab with ImmunoGenesis for Cancer Therapy
11 Dec 2024 //
GLOBENEWSWIRE
ImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS-001
28 Sep 2023 //
PR NEWSWIRE
ImmunoGenesis and Cancer Focus Fund Announce $4.5 Million
27 Jun 2023 //
PR NEWSWIRE
ImmunoGenesis to Present Pre-Clinical Data from Lead Program
03 Nov 2022 //
PRNEWSWIRE
Agenus Enters 3 New Clinical Collaborations
31 May 2022 //
CONTRACTPHARMA
ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology
14 Dec 2021 //
BIOSPACE
Data from ImmunoGenesis` Lead Programs Presented in Six Posters at Society
15 Nov 2021 //
PRNEWSWIRE
Data from ImmunoGenesis` Lead Programs to be Presented at SITC Conference
03 Nov 2021 //
PRNEWSWIRE
ImmunoGenesis Opens Research Lab, Adds Key Roles
27 Jul 2021 //
CONTRACT PHARMA